
COVID-19 news has slowed down in the last week, allowing different pharma developments to take centre stage. In the last …

The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …

The Royal Pharmaceutical Society (RPS) in Scotland has raised concerns that the Government’s contingency plans do not eliminate the risks …

A third (33%) of brits stockpile medicines, according to new research from Co-op Health. One in three British people never …

More than 60 different pharmaceutical compounds were detected in aquatic invertebrate larvae and riparian predators in six streams near Melbourne, …

The oral leukaemia treatment Tibsovo (ivosidenib) produced by Massachusetts-based Agios Pharmaceuticals has been approved for treatment of adult patients with …

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …

It’s been another packed week in the industry, with one of the biggest takeaways being that childhood obesity has rocketed …

Ardelyx has confirmed that its NHE3 inhibitor tenapanor met all its primary and secondary endpoints in the study of its …

Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …

New damning allegations have arisen concerning Afghanistan’s pharmaceutical industry, as the Medicine Importers Union claims that at least 40% of …

Gilead has announced that it has completed its acquisition of Kite Pharma after the deal was announced on 28 August …

AbbVie has expanded the operational capability of its facility located at the Tuas Biomedical Park in Singapore with the addition …

Police have raided the French headquarters of German drug manufacturer Merck KGaA over a scandal concerning its thyroid treatment Levothyrox, …